Presentation of the German Biotechnology Report 2026

Presentation of the German Biotechnology Report 2026
Go back

The German Biotech Report 2026 brings together EY thought leadership and leading voices from across the biotech ecosystem to examine how Germany and Europe can turn scientific excellence into global leadership. From AI‑driven discovery and next‑generation food and industrial biotechnology to precision medicine, cell therapy, and antimicrobial resistance, the report highlights biotechnology as a strategic pillar for health, sustainability, and economic resilience. Across perspectives, a clear message emerges: securing competitiveness and strategic autonomy will require faster translation of innovation into scale—enabled by smart regulation, new financing models, strong partnerships, and decisive execution.

Preliminary Agenda:

12.00  Welcome bioRN/ EY/ Technology Park Heidelberg 

12.10 Presentation results EY German Biotechnology Report by Klaus Ort

12:35  Impuls by Prof. Dr. Jochen Maas ‘A broader view on health – impact on science hubs’

12:55  Q&A /Panel

1:15   Wrap Up and Closing

Get Together /Drinks and Snacks

2.00pm end

register now

Our latest News

discover more
The Heidelberg and Mannheim University Hospitals consortium has taken first place in the Stern hospital rankings

The Heidelberg and Mannheim University Hospitals consortium has taken first place in the Stern hospital rankings

For the first time in 14 years, there has been a change at the top of the hospital rankings, which are published annually by the MINQ Institute in collaboration with Stern. In its very first year of existence, the Heidelberg and Mannheim University Hospitals Consortium has taken first place. More information in German below: Zusammen […]

read more
Presentation of the EY German Biotechnology Report 2026 in Heidelberg: Strong Innovation Ecosystems Are Key to Scaling Innovation

Presentation of the EY German Biotechnology Report 2026 in Heidelberg: Strong Innovation Ecosystems Are Key to Scaling Innovation

Heidelberg, 11 June 2026 – Germany continues to produce world-class science, breakthrough technologies and highly innovative biotechnology companies. However, the challenge is no longer generating innovation – it is creating the conditions that allow innovation to scale. This was one of the central messages emerging from the presentation of the EY German Biotechnology Report 2026, […]

read more
CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

Finnish animal welfare legislation (Government Decree 1165/2023) effective as of January 1, 2024, requires establishments to apply “appropriate pain relief” in association with ear notching identification method of laboratory rodents(1). However, there is a lack of scientific evidence whether the benefits of applying analgesia outweigh the additional stress related to handling and drug administration. Our […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp